Redeye: Bredband2 - Q3 Review – Continued Progress
Redeye returns with a positive view on the back of Bredband2’s Q3 2024 report which was largely in line with our expectations. We continue to see solid growth prospects accompanied by a stronger margin ahead.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/